| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/WSBM.1321 |
| P698 | PubMed publication ID | 26538017 |
| P50 | author | Jens B. Nielsen | Q16733372 |
| Francesco Gatto | Q55319005 | ||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Cancer genome landscapes | Q22242276 | ||
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Gene ontology: tool for the unification of biology | Q23781406 | ||
| The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism | Q24305332 | ||
| Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence | Q24310386 | ||
| Data, information, knowledge and principle: back to metabolism in KEGG | Q24568332 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| Recurring mutations found by sequencing an acute myeloid leukemia genome | Q24634204 | ||
| An integrated genomic analysis of human glioblastoma multiforme | Q24648860 | ||
| Autophagy-mediated tumor promotion | Q27011920 | ||
| MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool | Q27643976 | ||
| Comprehensive molecular characterization of clear cell renal cell carcinoma | Q27852374 | ||
| Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing | Q27860948 | ||
| On the Origin of Cancer Cells | Q27861025 | ||
| Network biology: understanding the cell's functional organization | Q27861027 | ||
| Metabolic pathways promoting cancer cell survival and growth | Q28086940 | ||
| Proliferation, cell cycle and apoptosis in cancer | Q28189476 | ||
| Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis | Q28242612 | ||
| Cancer genes and the pathways they control | Q28275089 | ||
| Energy metabolism in tumor cells | Q28288377 | ||
| Why do cancers have high aerobic glycolysis? | Q28290710 | ||
| Mutational landscape and significance across 12 major cancer types | Q28300353 | ||
| Regulation of cancer cell metabolism | Q28303890 | ||
| Discovery and saturation analysis of cancer genes across 21 tumour types | Q28305204 | ||
| Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT | Q28483779 | ||
| Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis | Q28595034 | ||
| The life history of 21 breast cancers | Q29614642 | ||
| Activation of a metabolic gene regulatory network downstream of mTOR complex 1 | Q29615179 | ||
| COSMIC: exploring the world's knowledge of somatic mutations in human cancer | Q29615725 | ||
| Interactome networks and human disease | Q29615773 | ||
| Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? | Q29616804 | ||
| c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism | Q29617213 | ||
| Metabolic reprogramming: a cancer hallmark even warburg did not anticipate | Q29617612 | ||
| Akt stimulates aerobic glycolysis in cancer cells | Q29619301 | ||
| Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis | Q33597162 | ||
| Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer | Q33931343 | ||
| Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma | Q34391844 | ||
| Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma | Q34405226 | ||
| Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. | Q34412152 | ||
| Gene expression. Statistics requantitates the central dogma | Q34465988 | ||
| Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE | Q34509501 | ||
| Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid | Q34853520 | ||
| Emerging landscape of oncogenic signatures across human cancers | Q35058708 | ||
| Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function | Q35223050 | ||
| Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth | Q35458543 | ||
| Extensive decoupling of metabolic genes in cancer | Q35593094 | ||
| Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin | Q35752935 | ||
| The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. | Q35764439 | ||
| Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism | Q36319414 | ||
| Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma | Q36342398 | ||
| A liaison between mTOR signaling, ribosome biogenesis and cancer | Q36615429 | ||
| Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF | Q36793719 | ||
| Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. | Q36850905 | ||
| Heterogeneity of tumor-induced gene expression changes in the human metabolic network | Q36927094 | ||
| Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development | Q37287417 | ||
| Metabolic regulation by p53 family members. | Q37298047 | ||
| mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc | Q37341834 | ||
| Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells | Q37577449 | ||
| Targeting metabolic transformation for cancer therapy. | Q37714309 | ||
| Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect | Q37783380 | ||
| Therapeutic targets in cancer cell metabolism and autophagy | Q38025264 | ||
| How cancer metabolism is tuned for proliferation and vulnerable to disruption | Q38059777 | ||
| Oncometabolomics in cancer research | Q38132912 | ||
| Making new contacts: the mTOR network in metabolism and signalling crosstalk | Q38189969 | ||
| Cancer: evolution within a lifetime | Q38257835 | ||
| Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery. | Q38311249 | ||
| Organ-Specific Cancer Metabolism and Its Potential for Therapy. | Q38441997 | ||
| Deoxyribonucleotide metabolism, mutagenesis and cancer | Q38572102 | ||
| Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia. | Q39049785 | ||
| PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. | Q39193337 | ||
| Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1 | Q41983843 | ||
| Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells? | Q42858457 | ||
| Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence | Q43120565 | ||
| New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism | Q44226601 | ||
| Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease | Q45745547 | ||
| Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes | Q53530417 | ||
| Renal cell carcinoma | Q56019530 | ||
| Systems Biology | Q57022542 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 23-35 | |
| P577 | publication date | 2015-11-05 | |
| P1433 | published in | Wiley interdisciplinary reviews. Systems biology and medicine | Q26842017 |
| P1476 | title | In search for symmetries in the metabolism of cancer | |
| P478 | volume | 8 |
| Q26771504 | Applications of Genome-Scale Metabolic Models in Biotechnology and Systems Medicine | cites work | P2860 |
Search more.